These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1664762)

  • 21. The 5-HT1-like receptor mediating reduction of porcine carotid arteriovenous shunting by RU 24969 is not related to either the 5-HT1A or the 5-HT1B subtype.
    Bom AH; Villalón CM; Verdouw PD; Saxena PR
    Eur J Pharmacol; 1989 Nov; 171(1):87-96. PubMed ID: 2612570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of "5-hydroxytryptamine1-like" receptors.
    Saxena PR; Duncker DJ; Bom AH; Heiligers J; Verdouw PD
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):198-204. PubMed ID: 3762734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor.
    Jansen I; Edvinsson L; Mortensen A; Olesen J
    Cephalalgia; 1992 Aug; 12(4):202-5. PubMed ID: 1326402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ergotamine and dihydroergotamine on 5-hydroxytryptamine-2A receptors in the isolated rat aorta.
    Kalkman HO; Schneider F
    Pharmacology; 1996 Dec; 53(6):351-5. PubMed ID: 9032799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein.
    Humphrey PP; Feniuk W; Perren MJ; Connor HE; Oxford AW; Coates LH; Butina D
    Br J Pharmacol; 1988 Aug; 94(4):1123-32. PubMed ID: 2850055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective vasoconstriction by alniditan in the carotid vascular bed of anaesthetized dogs.
    Van de Water A; D'Aubioul J; Van Gerven W; Van Ammel K; De Clerck F
    Eur J Pharmacol; 1996 Mar; 299(1-3):127-37. PubMed ID: 8901015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antimigraine agent alniditan selectively constricts porcine carotid arteriovenous anastomoses via 5-HT1B/1D receptors.
    De Vries P; Willems EW; Heiligers JP; Villalón CM; Saxena PR
    Eur J Pharmacol; 1998 Jun; 351(2):193-201. PubMed ID: 9687003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen.
    Saxena PR; Koedam NA; Heiligers J; Hof RP
    Cephalalgia; 1983 Jun; 3(2):71-81. PubMed ID: 6409416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of S9977 and dihydroergotamine in an animal experimental model for migraine.
    Villalón CM; Bom AH; Den Boer MO; Heiligers JP; Saxena PR
    Pharmacol Res; 1992; 25(2):125-37. PubMed ID: 1635891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serotonin agonists and antagonists in migraine].
    Ollat H
    Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of nitric oxide biosynthesis and carotid arteriovenous anastomotic shunting in the pig.
    van Gelderen EM; Saxena PR
    Br J Pharmacol; 1994 Mar; 111(3):961-7. PubMed ID: 8019774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constriction of porcine arteriovenous anastomoses by indorenate is unrelated to 5-HT1A, 5-HT1B, 5-HT1C or 5-HT1D receptor subtypes.
    Villalón CM; Bom AH; Heiligers JP; Den Boer MO; Saxena PR
    Eur J Pharmacol; 1990 Nov; 190(1-2):167-76. PubMed ID: 2076752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats.
    Roquebert J; Grenié B
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):30-7. PubMed ID: 2881518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sumatriptan-induced saphenous venoconstriction in the anaesthetized dog through 5-HT1-like receptor activation.
    Drieu la Rochelle C; O'Connor SE
    Br J Pharmacol; 1995 Oct; 116(4):2207-12. PubMed ID: 8564250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
    Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B
    Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.
    Silberstein SD; McCrory DC
    Headache; 2003 Feb; 43(2):144-66. PubMed ID: 12558771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the mechanism of 5-HT1 receptor-induced smooth muscle contraction in dog saphenous vein.
    Sumner MJ; Feniuk W; McCormick JD; Humphrey PP
    Br J Pharmacol; 1992 Mar; 105(3):603-8. PubMed ID: 1320980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ergotamine on cranial arteriovenous shunting in experiments with constant flow perfusion.
    Spierings EL; Saxena PR
    Eur J Pharmacol; 1979 Jun; 56(1-2):31-7. PubMed ID: 467512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal dihydroergotamine inhibits capsaicin-induced vasodilatation in the canine external carotid circulation via GR127935- and rauwolscine-sensitive receptors.
    Marichal-Cancino BA; González-Hernández A; Manrique-Maldonado G; Ruiz-Salinas II; Altamirano-Espinoza AH; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2012 Oct; 692(1-3):69-77. PubMed ID: 22841658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional myocardial perfusion and wall thickness and arteriovenous shunting after ergotamine administration to pigs with a fixed coronary stenosis.
    Schamhardt HC; Verdouw PD; van der Hoek TM; Saxena PR
    J Cardiovasc Pharmacol; 1979; 1(6):673-86. PubMed ID: 94633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.